Technical Analysis for NWBO - Northwest Bioth Cmn

Grade Last Price % Change Price Change
grade D 0.231 0.39% 0.0009
NWBO closed up 0.39 percent on Friday, October 18, 2019, on 33 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NWBO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 0.39%
50 DMA Resistance Bearish 0.39%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.39%
Bollinger Band Squeeze Range Contraction 0.39%
Lower Bollinger Band Walk Weakness 0.39%

Older signals for NWBO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.
Medicine Health Biotechnology RTT Cancer Clinical Medicine Antibodies Immunotherapy Cancer Immunotherapy Platform Technology Tumors Virotherapy Solid Tumor Cancers Northwest Biotherapeutics Tumor Antigen Vaccine
Is NWBO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.35
52 Week Low 0.18
Average Volume 1,555,659
200-Day Moving Average 0.2627
50-Day Moving Average 0.2343
20-Day Moving Average 0.2385
10-Day Moving Average 0.2339
Average True Range 0.0134
ADX 18.62
+DI 15.0943
-DI 14.2318
Chandelier Exit (Long, 3 ATRs ) 0.2123
Chandelier Exit (Short, 3 ATRs ) 0.2602
Upper Bollinger Band 0.2502
Lower Bollinger Band 0.2268
Percent B (%b) 0.18
BandWidth 9.811321
MACD Line -0.0031
MACD Signal Line -0.0016
MACD Histogram -0.0015
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2370
Resistance 3 (R3) 0.2373 0.2357 0.2360
Resistance 2 (R2) 0.2357 0.2341 0.2355 0.2357
Resistance 1 (R1) 0.2333 0.2332 0.2325 0.2330 0.2353
Pivot Point 0.2317 0.2317 0.2313 0.2315 0.2317
Support 1 (S1) 0.2293 0.2301 0.2285 0.2290 0.2267
Support 2 (S2) 0.2277 0.2292 0.2275 0.2263
Support 3 (S3) 0.2253 0.2277 0.2260
Support 4 (S4) 0.2250